NVAX - Novavax, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5105.86M
Enterprise Value 3348.44M
Trailing P/E N/A
Forward P/E 1-1.02
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)3.70
Price/Book (mrq)N/A
Enterprise Value/Revenue 312.18
Enterprise Value/EBITDA 6-2.14

Trading Information

Stock Price History

Beta (3Y Monthly) 2.58
52-Week Change 3-83.69%
S&P500 52-Week Change 36.34%
52 Week High 351.6000
52 Week Low 34.3800
50-Day Moving Average 35.2971
200-Day Moving Average 317.6333

Share Statistics

Avg Vol (3 month) 3825.61k
Avg Vol (10 day) 3555.95k
Shares Outstanding 523.47M
Float 23.19M
% Held by Insiders 10.95%
% Held by Institutions 134.42%
Shares Short (Jun 28, 2019) 44.56M
Short Ratio (Jun 28, 2019) 46.82
Short % of Float (Jun 28, 2019) 420.12%
Short % of Shares Outstanding (Jun 28, 2019) 419.43%
Shares Short (prior month May 31, 2019) 44.26M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 220/1
Last Split Date 3May 10, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)-596.25%

Management Effectiveness

Return on Assets (ttm)-42.88%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)28.62M
Revenue Per Share (ttm)1.48
Quarterly Revenue Growth (yoy)-58.70%
Gross Profit (ttm)-139.51M
EBITDA -162.61M
Net Income Avi to Common (ttm)-181.61M
Diluted EPS (ttm)-9.3680
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)100.19M
Total Cash Per Share (mrq)4.27
Total Debt (mrq)340.43M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.92
Book Value Per Share (mrq)-6.41

Cash Flow Statement

Operating Cash Flow (ttm)-169.36M
Levered Free Cash Flow (ttm)-91.93M